Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in ... unlike other technologies like CRISPR/Cas9, and theoretically ...

The University of Bayreuth's Biomaterials research group has, for the first time, successfully applied the CRISPR-Cas9 ...

An appeals court has opened another chapter in the long-running CRISPR patent saga. | An appeals court has opened another ...

CRISPR Therapeutics benefits from Casgevy’s approval and a deep pipeline, despite early rollout hurdles and cost challenges.

Scientists have bred spiders that weave red draglines, proving that the animals’ silk can be genetically re-engineered.

A federal appeals court said the patent office made legal errors in awarding foundational patents for CRISPR-Cas9 to the ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to ... wrestle with genetic redundancy and a lack of specificity in gene targeting. Here the authors develop a scalable CRISPR system ...

As the power of gene editing becomes more advanced ... is thought to be irresponsible by many in the field.' Crispr-Cas9 is a tool for making precise edits in DNA, discovered in bacteria.

an enzyme called Cas9 that snips DNA at precise locations and CRISPR guide molecules that deliver the Cas9 snippers to the gene that researchers want to knock out. When the cell repairs the break, ...

HG302’s developers have moved on to testing the treatment in humans as part of a multidose, dose-escalation study to understand the safety of CRISPR gene-editing therapy and its long-lasting ...

Vertex Pharma has teamed up with Orum Therapeutics to develop a conditioning regimen, used to prepare patients to receive gene-editing medicines, that it hopes will offer a more tolerable ...